Coagulation Factor Deficiencies and Pregnancy Loss

Aida Inbal; Laszlo Muszbek

doi:10.1055/s-2003-38832

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2003; 29(2): 171-174
DOI: 10.1055/s-2003-38832

Coagulation Factor Deficiencies and Pregnancy Loss

Aida Inbal¹ , Laszlo Muszbek²

¹Associate Professor, and Acting Director, Institute of Thrombosis and Hemostasis, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel
²Department of Clinical Biochemistry and Molecular Pathology, Medical and Health Science Center, University of Debrecen, Hungary

Abstract

ABSTRACT

Of all the coagulation factor deficiencies, only deficiency of factor XIII (FXIII) and fibrinogen are associated with pregnancy loss. FXIII deficiency and a complete or partial deficiency of fibrinogen are associated with bleeding since childhood, impaired wound repair, and recurrent spontaneous abortions. Both FXIII and fibrinogen play an essential role in placental implantation and maintenance of pregnancy. The causes of miscarriages in FXIII or fibrinogen-deficient women is discussed and an appropriate treatment advocated.

KEYWORDS

Factor XIII deficiency - afibrinogenemia - miscarriages

Volltext

Referenzen

REFERENCES

1 Schwartz M L, Pizzo S V, McKee P A. Human factor XIII from plasma and platelets. J Biol Chem . 1973; 248 1395-1407
2 Muszbek L, Yee V C, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res . 1999; 94 271-305
3 Fisher S, Rikover M, Naor S. Factor 13 deficiency with severe hemorrhagic diathesis. Blood . 1966; 28 34-39
4 Anwar T, Miloszewski K. Factor XIII deficiency. Br J Haematol . 1999; 107 468-484
5 Ádány R, Muszbek L. Immunohistochemical detection of Factor XIII subunit a in histiocytes of human uterus. Histochemistry . 1989; 91 169-174
6 Asahina T, Kobayashi T, Okada Y. et al . Studies on the role of adhesive proteins in maintaining pregnancy. Horm Res . 1998; 50(Suppl 2) 37-45
7 Ádány R, Glukhova M, Kabakov A Y. et al . Characterization of connective tissue cells containing factor XIII subunit a. J Clin Pathol . 1988; 41 49-56
8 Kappelmayer J, Bacsko G, Kelemen E. et al . Onset and distribution of factor XIII-containing cells in the mesenchyme of chorionic villi during early phase of human placentation. Placenta . 1994; 15 613-623
9 Muszbek L, Ádány R, Kávai M. et al . Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit A antigen and transglutaminase activity. Thromb Haemost . 1988; 59 231-235
10 Rodeghiero F, Castaman G C, Di Bona E. et al . Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitute therapy. Blut . 1987; 55 45-48
11 Boda Z, Pfliegler G, Muszbek L. et al . Congenital factor XIII deficiency with multiple benign breast tumors and successful pregnancy with substitutive therapy. Haemostasis . 1989; 19 348-352
12 Kobayashi T, Terao T, Kojima T. et al . Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest . 1990; 29 235-238
13 Burrows R F, Ray J G, Burrows E A. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Survey . 2000; 55 103-8
14 Wartiovaara J, Leivo I, Virtanen I. et al . Cell surface and extracellular matrix glycoprotein fibronectin. Expression in embryogenesis and in teratocarcinoma differentiation. Ann NY Acad Sci . 1978; 312 132-141
15 Vicovac L, Aplin J D. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat . 1966; 156 202-216
16 Kobayashi T, Asahina T, Okada Y. et al . Studies on the localization of adhesive proteins associated with the development of extravillous cytotrophoblast. Trophoblast Res . 1999; 13 35-53
17 Asahina T, Kobayashi T, Okada Y. et al . Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta . 2000; 21 388-393
18 Brackmann H H, Egbring R, Feister A. et al . Pharmacokinetics and tolerability of factor XIII concentrates prepared from human placenta or plasma: A crossover randomized trial. Thromb Haemost . 1995; 74 622-625
19 Mikkola H, Muszbek L, Laiho E. et al . Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. Blood . 1997; 89 1279-1287
20 Hayano Y, Ima N, Kasaraura T. Studies on the physiologic changes of blood coagulation factor XIII during pregnancy and their significance. Acta Obstet Gynaecol Jpn . 1982; 34 469-477
21 Nossel H L, Lanzkowsky P, Levy S. et al . A study of coagulation levels in women during labor and their newborn infants. Thromb Diath Haemorrhag . 1966; 16 185-197
22 Biland L, Duckert F. Coagulation factors in the newborn and his mother. Thromb Diath Haemorrhag . 1973; 29 644-651
23 Coopland A, Alkjaersig N, Fletcher A P. Reduction in plasma factor XIII (fibrin stabilizing factor) concentration during pregnancy. L Lab Clin Med . 1969; 73 144-153
24 van Wersch W J, Vooijs M E, Ubachs J M. Coagulation factor XIII in pregnant smokers and non-smokers. Int J Clin Lab Res . 1997; 27 68-71
25 Stirling Y, Woolf L, North W RS. et al . Haemostasis in normal pregnancy. Thromb Haemost . 1984; 52 176-182
26 Ogasawara M S, Aoki K, Katano K. et al . Factor XII but not protein C, protein S, antithrombin III, or factor VIII is a predictor of recurrent miscarriage. Fertil Steril . 2001; 75 916-919
27 Galanakis D K. Fibrinogen anomalies and disease. A clinical update. Hematol Oncol Clin N Am . 1992; 6 1171-1187
28 Doolittle R F. The molecular biology of fibrin. In: Stamatoyannopoulos GS, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases Philadelphia, PA: WB Saunders 1994: 701-723
29 Bennett J S. Integrin structure and function in hemostasis and thrombosis. Ann NY Acad Sci . 1991; 614 214-228
30 Mosesson M W. Dysfibrinogenemia and thrombosis. Semin Thromb Hemost . 1999; 25 311-319
31 Ridgway H J, Brennan S O, Faed J M, George P M. Fibrinogen Otago: a major α chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. Br J Haematol . 1997; 98 632-639
32 Suh T T, Holmback K, Jensen N. et al . Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev . 1995; 9 2020-2033
33 Inamoto Y, Terao T. First report of a case of congenital afibrinogenemia with successful delivery. Am J Obstet Gynecol . 1985; 153 803-804
34 Gilabert J, Reganon E, Vila V. et al . Congenital hypofibrinogenemia and pregnancy: obstetric and hematological management. Gynecol Obstet Invest . 1987; 24 271-276
35 Ingram G IC, McBrien D J, Spencer H. Fatal pulmonary embolus in congenital fibrinopenia. Report of two cases. Acta Hematol . 1966; 35 56-62
36 MacKinnon H H, Fekete J F. Congenital afibrinogenemia: vascular changes and multiple thromboses induced by fibrinogen infusions and contraceptive medication. J Can Med Assoc . 1971; 140 597-599
37 Beck E A. Congenital abnormalities of fibrinogen. Clin Haematol . 1979; 8 169-181